Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model

Clinical Cancer Research

Volumn 2, Issue 10, 1996, Pages 1659-1664

  Eicher, Susan A ^a,c   Clayman, Gary L ^a   Liu, Ta Jen ^a   Shillitoe, Edward J ^b   Storthz, Karen A ^a   Roth, Jack A ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; PROTEIN P53; VIRUS VECTOR;

ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; FIBROBLAST; GENE THERAPY; GENETIC TRANSDUCTION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MODEL; PRIORITY JOURNAL;

ADENOVIRIDAE; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; ORGAN CULTURE TECHNIQUES; PEPTIDES; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029965623     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Somers, K. D., Merrick, M. A., Lopez, M. E., Incognito, L. S., Schechter, G. L., and Casey, G. Frequent p53 mutations in head and neck cancer. Cancer Res., 52: 5997-6000, 1992.
2. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
3. Liu, T-J., El-Naggar, A. K., McDonnell, T. J., Steck, K. D., Wang, M., Taylor, D. L., and Clayman, G. L Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res., 55; 3117-3122, 1995.
4. Hopp, T. P., Prickett, K. S., Price, V. L., Libby, R. T., March, C. J., Cerretti, D. P., Urdal, D. L., and Conlon, P. J. A short polypeptide marker sequence useful for recombinant protein identification and purification. BioTechnology, 6: 1204-1210, 1988.
5. Rupniak, H. T., Rowlatt, C., Lane, E. B., Steele, J. G., Trejdosiewicz, L. K., Laskiewicz, B., Povey, S., and Hill, B T. Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J. Natl. Cancer Inst., 75: 621-635, 1985.
6. Kopan, R., Traska, G., and Fuchs, E. Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization. J. Cell Biol., 105; 427-440, 1987.
7. Zhang, W-W., Fang, X., Mazur, W., French, B. A., Georges, R. N., and Roth, J. A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther., 1: 5-13, 1994.
8. Liu, T-J., Zhang, W-W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
9. Overholt, S. M., Liu, T-J., Taylor, D. L., Wang, M., El-Naggar, A. K., Shillitoe, E., Adler-Storthz, K., Zhang, W-W., Roth, J. A., and Clayman, G. L. Head and neck squamous cell carcinoma growth suppression using adenovirus-p53-FLAG: an effective marker for gene therapy trials. Cancer Gene Ther., in press, 1996.
10. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
11. Gregoire, V., Van, T. N., Stephens, C., Brock, W. A., Milas, L., Plunkett, W., and Hittelman, W. N. The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. Cancer Res., 54: 6201-6209, 1994.
12. Nawroz, H., van der Riet, P., Hruban, R. H., Koch, W., Ruppert, J. M., and Sidransky, D. Allelotype of head and neck squamous cell carcinoma. Cancer Res., 54: 1152-1155, 1994.
13. van der Riet, P., Nawroz, H., Hruban, R. H., Corio, R., Tokino, K., Koch, W., and Sidransky, D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res., 54: 1156-1158, 1994.
14. O'Malley, B. W., Jr., Chen, S. H., Schwartz, M R., and Woo, S. L. C. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res., 55: 1080-1085, 1995.
15. Wilson, J. L., Dollard, S. C., Chow, L. T., and Broker, T. R. Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures. Cell Growth & Differ., 3: 471-483, 1992.
16. Clayman, G. L., El-Naggar, A. K., Roth, J A., Zhang, W-W., Goepfert, H., Taylor, D. L., and Liu, T-J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res., 55: 1-6, 1995.
17. Clayman, G. L., Trapnell, B. C., Mittereder, N., Liu, T-J., Eicher, S., Zhang, S., and Shillitoe, E. J. Transduction of normal and malignant oral epithelium by an adenovirus vector. the effect of dose and treatment time on transduction efficiency and tissue penetration. Cancer Gene Ther., 2: 105-111, 1995.